key: cord-0746144-2uf7rd0l
authors: Singh, Urvashi B.; Deb, Sushanta; Chaudhry, Rama; Bala, Kiran; Rani, Lata; Gupta, Ritu; Kumari, Lata; Ahmed, Jawed; Gaurav, Sudesh; Perumalla, Sowjanya; Nizam, Md.; Mishra, Anwita; Stephenraj, J.; Shukla, Jyoti; Bhardwaj, Deepika; Nayer, Jamshed; Aggarwal, Praveen; Kabra, Madhulika; Ahuja, Vineet; Sinha, Subrata; Guleria, Randeep
title: SARS-CoV-2 Omicron Variant Wave in India: Advent, Phylogeny and Evolution
date: 2022-05-16
journal: bioRxiv
DOI: 10.1101/2022.05.14.491911
sha: 19b2de57075a15f8f844c1b1e9a762b2778b09d6
doc_id: 746144
cord_uid: 2uf7rd0l

SARS-CoV-2 evolution has continued to generate variants, responsible for new pandemic waves locally and globally. Varying disease presentation and severity has been ascribed to inherent variant characteristics and vaccine immunity. This study analyzed genomic data from 305 whole genome sequences from SARS-CoV-2 patients before and through the third wave in India. Delta variant was responsible for disease in patients without comorbidity(97%), while Omicron BA.2 caused disease primarily in those with comorbidity(77%). Tissue adaptation studies brought forth higher propensity of Omicron variants to bronchial tissue than lung, contrary to observation in Delta variants from Delhi. Study of codon usage pattern distinguished the prevalent variants, clustering them separately, Omicron BA.2 isolated in February grouped away from December strains, and all BA.2 after December acquired a new mutation S959P in ORF1b (44.3% of BA.2 in the study) indicating ongoing evolution. Loss of critical spike mutations in Omicron BA.2 and gain of immune evasion mutations including G142D, reported in Delta but absent in BA.1, and S371F instead of S371L in BA.1 could possibly be due to evolutionary trade-off and explain very brief period of BA.1 in December 2021, followed by complete replacement by BA.2.

The origin of SARS-CoV-2 has been ascribed to a recombination in Bats, enriching it with the capability to utilize enzyme furin from human cells, enabling the spike protein to bind the Neuropilin1 on human cells, hence facilitating cellular entry and replication. The virus was thus different from SARS and MERS. The S:D614G mutation improved its ability to bind to ACE2 receptors, further enabling the ease of infecting humans, and thus widespread transmission 1 . The H69/V70 deletion enabled increase in infectivity by two-fold and the N501Y and K417N enabled stronger binding with ACE2 receptors 2 , the latter along with E484K mutation were shown to enable reduction in neutralization by antibodies 3 . The variant spread to all continents and was responsible for a large number of cases globally. It was detected at faster rates than previous surges and was designated a variant of concern. Countries were advised to enhance surveillance and sequencing efforts, field investigations to understand impact of this variant on COVID-19 epidemiology, disease severity, immune response, virulence, transmissibility, immune, diagnostic or therapeutic escape 4 .

In February 2022, the new sub-lineage BA.2 was reported to be spreading widely. WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution recommended that this sub-lineage should continue to be considered a variant of concern, and remain classified as Omicron, based on data available on its severity, reinfection capability, diagnostics 4 . In India, Omicron transmission continued through December 2021-February 2022. December 2021 strains were BA.1 to begin with, but soon BA.2 replaced as the predominant strain. Most cases were reported as mild, attributable to reduced severity, infrequent lung involvement and higher population immunity. Higher number of cases indicating higher transmission resulted in more hospital admissions.

Deaths were primarily reported in unvaccinated population 6 .

Our study was designed to understand the genomic differences and evolutionary changes in the variants prevalent in and around the city of Delhi, before and during the third wave of SARS CoV-2.

Sample Processing: Samples were collected as part of routine testing for patients reporting to the Emergency Department at the All India Institute of Medical Sciences, with symptoms of high grade fever, shortness of breath and headache. The samples were subjected to whole-genome sequencing following the IEC approval (IEC-679/03.07.2020,RP-32/2020).

Nasopharyngeal and oro-pharyngeal swabs were collected from individuals presenting to Emergency Department, and tested using Cartridge based Nucleic Acid Amplification Test (CBNAAT) in the Biosafety Level-3 laboratory, Department of Microbiology from June 2021 to March 2022. Patients presenting with respiratory symptoms suggestive of COVID-19, and patients planned for emergency interventions were enrolled in the study. Sample was collected as per standard procedures using a nylon-flocked swab and transported to the laboratory in Viral Transport medium (TrueNat uses Viral lysis buffer). Samples were subjected to CBNAAT in the BSL-3 laboratory (either GeneXpert or TrueNat) 7, 8 . Xpert Xpress SARS-CoV-2 assay detects envelope (E), and nucleocapsid (N2) genes of SARS-CoV2 with sample processing control. Table S1 .

The SARS-CoV-2 genome sequences obtained from this study were subjected to maximum likelihood (ML) phylogenetic analysis using IQ-TREE v2.1.2 11 . The whole-genome sequences were aligned using were aligned using MAFFT v7.475 12 , the aligned sequences were further used as input for IQ-TREE program build in nextstrain pipeline and downstream analysis steps were followed to generate the phylogenetic tree. Generated tree file were visualized using the FigTree program v1.4.4 (available at: http://tree.bio.ed.ac.uk/software/figtree/).

To determine the phylogenetic clade, isolated SARS-CoV-2 genomes were compared against the global Nextstrain database (https://nextstrain.org/ncov/global) using the combined package of Augur, the MAFFT and the IQ-tree software embedded in Nextstrain pipeline. The nucleotide and amino acid substitution analysis were performed by augur pipeline and other accessory module of nextstrain pipeline 13 .

The codon usage analysis was performed using Bash and R scripts of CUBES package 14 . The modal codon usages 15 were calculated for the genes from given viral genomes with the help of calculate_modals2.pl script implemented in CUBES package (https://github.com/maurijlozano/ CUBES).The correspondance analysis (CA) 16 females. Among them 31.6% had received vaccination and 68.5% patients had some comorbidity (9.6% chronic pulmonary disease, 26.3% cancer, 14.4% hypertension, 7.7% chronic kidney, 10% cardiovascular ailment, 11.5% Diabetes mellitus, 9% neurological disease, 3.8% hypothyroidism and 22% less severe health issues). Of those with comorbidities, 62% were admitted while the remaining advised home isolation. Death was reported in 3.3% study population. Delta variants affected patients without any comorbidity in 97% (30/31), BA.1 affected 50% patients without comorbidity, BA.2 lead to disease in 23% patients without comorbidity, while 77% patients had Diabetes, hypertension, or some other comorbidity. (Table S1 ).

The S2) . A time-scale phylogenetic tree constructed using Next-strain pipeline to identify the phyletic position of Delhi isolates in global context, our isolates are represented in clades with specific colored dots on global phylogenetic tree (Fig. 1) .

In this study human tissues from two main anatomic sites (Lung and Upper respiratory tract) that are reported to harbor a high viral load during COVID-19 infection were selected for tissue specific adaptation analysis of SARS-CoV-2 variants. The similarity index (SiD) estimates similarity between host and pathogen codon usage profile, and has been exploited to measure viral adaptation to the host 20 . The SiD value ranges from 0 to 1, if the value is close to 1 it indicates low viral adaptive capability inside the host system 21 . In the present study it has been observed that SiD value of Delta variant is relatively lower for lung tissue, however unlike delta, Omicron shows lower SiD value for upper respiratory tract (Fig. 2) .

A filtration criterion of (NNN= ≤ 1%) was applied to genomes for mutation analysis. After filtration, 31

Delta and 185 Omicron genomes were analyzed and found to have 1177 and 11488 amino acid substitutions in Delta and Omicron genomes respectively. Four substitutions are shared among all variants, two (T478K and D614G) in S glycoprotein and two (T3255I and P314L) in ORF1a and ORF1b, respectively (Table S2 and S3). Nearly 50% of substitutions belong to the Spike region in the Omicron genomes, 57% of total spike substitutions were confined to RBD (receptor binding domain)

region . An average of 17.2 and 60.6 synonymous mutations were recorded in Delta and Omicron variants, respectively. Gene-specific amino acid mutation profiles of Delta and Omicron variants were compared (Fig. 3) . Comparison of critical spike mutations was performed between BA.1 and BA.2 variants, three mutations (S371L, G446S and G496S) reported to be immune evasion mutations 22,23 , were found in Omicron BA.1 but were absent from BA.2 variant, while three other immune evasion mutations were gained in 98% of BA.2 study isolates, T376A, D405N and R408S in the Spike region 24 . Two mutations were gained (G142D and S371F) by BA.2 variant (Table S3) 

A comprehensive analysis of codon usage frequency was performed to understand the trends of evolution currently operating on the total genetic contents of the SARS-CoV-2 strains circulating in Delhi. A significant difference in codon usage among the genomes of SARS-CoV-2 variants was observed between Delhi isolates from June-2021 to February-2022 (Fig. 4,a1) . The figure shows the Delta genome clustered (red) separately from the Omicron genome (yellow) (Fig. 4,a1) , which indicates Delta variants are genetically distant from Omicron variants and a notable genetic distance was observed among the currently circulating Omicron variants of Delhi (Fig. 4,a2) . However, unlike Omicron variant, not much genetic variability was observed among the Delta variants of Delhi. Few genomes were represented as a single dot (singleton) in figure 4, mainly due to the high ambiguity (Multiple Ns) in its nucleotide sequence. In addition it is evident from the analysis that the genomes of SARS CoV-2 variants were enriched in C and U ending codons (Fig. 4,b1-b3, Right graph) .

This study demonstrates tissue adaptation, whole genome codon usage pattern and evolution of the (Fig. 4) , highlighting genetic diversity of February isolates from December and January. The genetic diversity in BA.2 isolates reflects on the codon usage plot.

Multiple separate clusters of the Omicron genomes represent the genetic distance among the Omicron variants currently dominating in Delhi (Fig. 4, a2; left graph) . The findings indicate that the Omicron variant in Delhi is under the process of genetic evolution, and could give rise to multiple Omicron variants in the near future.

Simmonds et al discussed C→U SNP, as being predominant in all SARS-CoV-2 variants. We found similar substitutions in Delta and Omicron in Delhi uniformly (Fig. 4 , b1-b3 ; right graphs). The U ending codons were found approximately four times higher than other substitutions 29, 30 .

Several reports have ascribed lesser severity of Omicron variants to lower lung involvement in comparison to Delta variant and higher replication in bronchi 31 The phylogenetic relationship and mutation burden across SARS-CoV-2 variants isolated from Delhi.

The radial axis shows the total number of mutations in different lineages.

Nucleotide mutations in Omicron and Delta genomes. Boxes contain the 25th and 75th percentiles, and whiskers show the minimum and maximum values.

Metadata of Delhi SARS-CoV2 isolates with GISAID Accession Number.

In all 31 Delta sequences were submitted to GISAID. Mutations observed in different genes of Delta genome sequences are listed below with percentage of abundance of each mutation amongst the sequences. ORF1a includes A1306S (84%), T1395A (3%), P2046L(88%), P2287S (88%), A2529V(3%),V2930L(88%), T3255I(88%), L3606F(3%), T3646A (88%). ORF1b includes P314L

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. The Lancet Microbe

Virological characteristics of SARS-CoV-2 BA. 2 variant

Assessing a chip based rapid RTPCR test for SARS CoV-2 detection (TrueNat assay): A diagnostic accuracy study. Hasnain SE

Xpert Xpress SARS-CoV-2. (Package insert.) US Food and Drug Administration

A new coronavirus associated with human respiratory disease in China

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis

MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform

Nextstrain: real-time tracking of pathogen evolution

Codon Usage Optimization in the Prokaryotic Tree of Life: How Synonymous Codons Are Differentially Selected in Sequence Domains with Different Expression Levels and Degrees of Conservation

Modal codon usage: assessing the typical codon usage of a genome

Codon usage in yeast: cluster analysis clearly differentiates highly and lowly expressed genes

PJ. Analysis of codon usage

Proteomics. Tissue-based map of the human proteome

CAIcal: a combined set of tools to assess codon usage adaptation

On the correct interpretation of similarity index in codon usage studies: Comparison with four other metrics and implications for Zika and West Nile virus

The distribution of synonymous codon choice in the translation initiation region of dengue virus

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner

Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study

An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2

Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short-and Long-Term Evolutionary Trajectories. mSphere

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo

Mutational and phylogenetic analyses of the two lineages of the Omicron variant

Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein

Omicron variant losing its critical mutations in the receptor-binding domain

Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions

Determinants of Spike Infectivity, Processing and Neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2. preprint

Genetic Variants of SARS-CoV-2-What Do They Mean?

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

G662S( 100%), P1000L(100%), A1918V (88%). Spike region includes S13T (3%)

T95I (72%), Y145H (3%), E156-(100%), F157-(100%), R158G (100%)

L452R (94%), T478K (94%), D614G (94%), P681R (94%), D950N (97%)

ORF7a includes V82A (94%) and T120I (97%) ORF7b includes T40I (88%), ORF8 includes Y42C (3%), D119-(38%) and F120-(100%). N gene includes D63G (100%), R203M (100%), G215C (88%) and D377Y (100%)

A total of 185 Omicron (5 Omicron BA.1+180 Omicron BA.2) sequences were submitted to GISAID

Mutations in different genes of Omicron genome sequences are listed below with percentage of abundance of each mutation amongst the submitted sequences. Mutations in ORF1a include S135R

T842I (98%), G1307S (98%), R1421K (7%), L3027F (98%), T3090I (98%), L3201F (98%), T3255I (100%), P3395H (100%), S3675-(100%), G3676-(100%) and F3677-(98%). Mutations in ORF1b include P314L (100%), R1315C (98%), I1566V (100%), T2163I (98%) and S959P(44.3%)

Mutations in Spike include T19I (87%), L24-(97%), P25-(97%), P26-(97%), A27S (97%), G142D (97%), V213G (96%), G339D (100%), S371F (98%), S373P (100%), S375F (100%)

D405N (98%), R408S (98%), K417N (100%), S477N (100%), T478K (100%)

Q493R (100%), Q498R (100%), N501Y (100%),Y505H (100%)

N679K (100%), P681H (96%), N764K (100%), D796Y (100%), Q954H (100%) and N969K (100%). Mutations in ORF3a include T223I (97%). Mutations in E gene include T9I (98%)

Mutations in M gene include Q19E (98%) and A63T (100%).Mutations in ORF6 include D61L (96%)

N gene include P13L (100%), E31-(100%), R32-(100%)

Immune evasion mutation S371L present in Omicron BA.1 was substituted by S371F (98%), better immune evasion mutation in BA